This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2000 Feb;46(2):147-9.

doi: 10.1136/gut.46.2.147.

Barrett's oesophagus and proton pump inhibitors: a pathological perspective

Affiliations

PMID: 10644302
PMCID: PMC1727813
DOI: 10.1136/gut.46.2.147

Barrett's oesophagus and proton pump inhibitors: a pathological perspective

N A Shepherd. Gut. 2000 Feb.

. 2000 Feb;46(2):147-9.

doi: 10.1136/gut.46.2.147.

Author

Affiliation

¹ Department of Histopathology Gloucestershire Royal Hospital Great Western Road Gloucester, GL1 3NN, UK. n.shepherd@virgin.net

PMID: 10644302
PMCID: PMC1727813
DOI: 10.1136/gut.46.2.147

No abstract available

PubMed Disclaimer

Comment in

Proton pump inhibitors for Barrett's oesophagus.
Peters FT. Peters FT. Gut. 2000 Jul;47(1):154-5. doi: 10.1136/gut.47.1.154a. Gut. 2000. PMID: 10917749 Free PMC article. No abstract available.

Similar articles

Proton pump inhibitors for Barrett's oesophagus.
Triadafilopoulos G. Triadafilopoulos G. Gut. 2000 Feb;46(2):144-6. doi: 10.1136/gut.46.2.144. Gut. 2000. PMID: 10644301 Free PMC article. No abstract available.
The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
Dunbar KB, Souza RF, Spechler SJ. Dunbar KB, et al. Gastroenterol Clin North Am. 2015 Jun;44(2):415-24. doi: 10.1016/j.gtc.2015.02.010. Epub 2015 Mar 18. Gastroenterol Clin North Am. 2015. PMID: 26021202 Review.
Oesophageal pH monitoring in Barrett's oesophagus.
Neumann CS, Cooper BT. Neumann CS, et al. Gut. 2003 Jan;52(1):153; author reply 153-4. doi: 10.1136/gut.52.1.153-a. Gut. 2003. PMID: 12477781 Free PMC article. No abstract available.
The Role of Acid Suppression in Barrett's Esophagus.
Elias PS, Castell DO. Elias PS, et al. Am J Med. 2017 May;130(5):525-529. doi: 10.1016/j.amjmed.2016.12.032. Epub 2017 Feb 1. Am J Med. 2017. PMID: 28159599 Review.
Does the treatment of proton pump inhibitors reduce dysplasia or adenocarcinoma development in Barrett's esophagus?
Akın H, Aydın Y. Akın H, et al. Turk J Gastroenterol. 2017 Dec;28(Suppl 1):S31-S32. doi: 10.5152/tjg.2017.09. Turk J Gastroenterol. 2017. PMID: 29199164 Review.

See all similar articles

Cited by

Medication usage and the risk of neoplasia in patients with Barrett's esophagus.
Nguyen DM, El-Serag HB, Henderson L, Stein D, Bhattacharyya A, Sampliner RE. Nguyen DM, et al. Clin Gastroenterol Hepatol. 2009 Dec;7(12):1299-304. doi: 10.1016/j.cgh.2009.06.001. Epub 2009 Jun 10. Clin Gastroenterol Hepatol. 2009. PMID: 19523538 Free PMC article.
Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.
Hao J, Zhang B, Liu B, Lee M, Hao X, Reuhl KR, Chen X, Yang CS. Hao J, et al. Int J Cancer. 2009 Mar 15;124(6):1270-5. doi: 10.1002/ijc.24077. Int J Cancer. 2009. PMID: 19058177 Free PMC article.
Proliferative activity in Barrett's esophagus before and after antireflux surgery.
Chen LQ, Hu CY, Gaboury L, Pera M, Ferraro P, Duranceau AC. Chen LQ, et al. Ann Surg. 2001 Aug;234(2):172-80. doi: 10.1097/00000658-200108000-00006. Ann Surg. 2001. PMID: 11505062 Free PMC article.

References

1. J Clin Pathol. 1981 Aug;34(8):866-70 - PubMed
1. Gut. 1999 Oct;45(4):489-94 - PubMed
1. Am J Gastroenterol. 1988 May;83(5):510-2 - PubMed
1. Am J Gastroenterol. 1993 Mar;88(3):402-8 - PubMed
1. Gastroenterology. 1993 Jun;104(6):1686-91 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources